FILTER

Refine your search with the following facets to narrow down your results.

939 Current news from the industry diagnostics

ExonHit Announces Successful Completion of the First Phase of EHT Dx14 Ongoing Clinical Validation

31-Mar-2011 - ExonHit Therapeutics announced successful completion of the first phase of the validation study of EHT Dx14, a new transcriptomic signature allowing to differentiate, at molecular level, benign breast tumors from malignant ones.“These very promising first results confirm EHT Dx14 capability to ...

breast cancer diagnostic tests

mtm’s p16/Ki-67 dual immuno-staining identifies high-grade cervical disease in ASC-US and LSIL with high sensitivity and specificity

31-Mar-2011 - mtm laboratories announced the publication of a new paper showing that dual staining for p16 and Ki-67 can pinpoint the underlying high-grade cervical disease with a high degree of sensitivity and specificity in women with ASC-US or LSIL cytology results. These are a group of patients currently ...

biomarker HPV

Seegene and Molzym partner on automated molecular sepsis diagnostics

28-Mar-2011 - Seegene and Molzym announced a partnership on the automated Magicplex™ Sepsis, a new multi-pathogen screening test capable of quick and accurate identification of over 90 leading sepsis-causing pathogens. "The Magicplex Sepsis Test will be the new gold standard for performing accurate, rapid and ...

sepsis

Abbott's New HIV-1 Qualitative Assay Improves Testing Access in Remote Areas for Children and Adults

25-Mar-2011 - Abbott announced that it has received CE-Mark for a new qualitative PCR-based HIV-1 test that produces highly accurate results from dried blood spot and plasma specimens. The new assay is a long-awaited diagnostic tool for health officials in African nations and other resource-limited areas to ...

Abbott HIV PCR

First Patient Included in Multicenter Study to Evaluate SIRS-Lab’s Diagnostic Test for Blood-Stream Infection

24-Mar-2011 - SIRS-Lab announced the inclusion of the first patient in a 1000-patient clinical study evaluating their molecular pathogen test VYOO. The multicenter trial, performed in 11 key centers across Germany and initiated in February 2011, will deliver data about the utility of the PCR test compared to ...

molecular diagnostics sepsis

Dako and Epitomics enter into strategic alliance on developing and launching IHC diagnostic monoclonal antibodies

23-Mar-2011 - Dako Denmark A/S and Epitomics, Inc. announced that they have entered into a collaboration which will allow the companies to unite competencies to provide the Anatomic Pathology market with state-of-the-art antibodies.Dako's expertise within the field of human cancer diagnostics, including ...

diagnostics monoclonal antibodies

Non-invasive tool to diagnose endometriosis

22-Mar-2011 - British scientists have used infrared spectroscopy to identify biochemical differences between endometrial tissue growing outside the uterus (ectopic) and the endometrial tissue of the uterus (eutopic). They also compared the results with tissue from endometriosis-free women (benign ...

endometriosis infrared spectroscopy

Epistem Announces Collaboration With sanofi-aventis

21-Mar-2011 - Epistem plc announced a collaboration with sanofi-aventis U.S. Inc. relating to the use of Epistem's proprietary biomarker gene expression profiling and immunohistochemistry technologies. Under the terms of the agreement sanofi-aventis has entered into a 3 year collaboration with Epistem to ...

biomarkers oncology Sanofi-aventis

Pronota and Molecuence announce collaboration in protein biomarker discovery

23-Feb-2011 - Pronota NV announced that it has entered into an agreement with Molecuence Corporation, a wholly owned subsidiary of Mitsubishi Chemical Corporation, to discover and validate protein biomarkers in stroke. Pronota will apply its proprietary platforms for protein biomarker discovery ...

biomarker Mitsubishi stroke